N-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia. Vecka M, Dušejovská M, Stankova B, Zeman M, Vavrova L, Kodydkova J, Slaby A, Zak A. Controlled Clinical Trial 2012; 33(Suppl 2): 87-92 PubMed PMID: 23183517 Keywords: Adult, Aged, Atherosclerosis:drug therapy, Drug Therapy, Combination, Dyslipidemias:drug therapy, Fatty Acids, Omega-3:administration & dosage, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors:administration & dosage, Hypertriglyceridemia:dr. Citation BACKGROUND: Atherogenic dyslipidemia contributes substantially to the residual cardiovascular risk. The aim of this study was to examine t..... Read abstract Full text PDF